Ignite Creation Date:
2025-12-24 @ 3:06 PM
Ignite Modification Date:
2026-05-15 @ 12:33 PM
Study NCT ID:
NCT06621459
Status:
RECRUITING
Last Update Posted:
2024-10-01
First Post:
2024-09-27
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Retrospective Observational Study of the Safety and Toxicity Management of Abemaciclib in Combination with Adjuvant Hormone Therapy in Patients with RH+ ,HER2-nonoveramplified Breast Cancer, Real-life Data (MONARCHE29)
Sponsor:
University Hospital, Brest
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
29BRC24.0244 - MONARCHE29
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None